In focus · trending topic

Andrew Van Vurst

1 stories · following the connections

BioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business Development

By Nasdaq OMXMar 13, 2018, 10:16 PM UTC